Impact of recurrent mutations on progression-free survival in CLL patients treated with front line rituximab-based regimens.

• Authors: ŠPUNAROVÁ Michaela; MALČÍKOVÁ Jitka; TOM Nikola; BORSKÝ Marek; BRYCHTOVÁ Yvona; DOUBEK Michael; PANOVSKÁ Anna; DIVÍŠKOVÁ Eva; MRÁZ Marek; POSPÍŠILOVÁ Šárka; MAYER Jiří; TRBUŠEK Martin
• Year of publication: 2017
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine
• Description: Impact of recurrent mutations on progression-free survival in CLL patients treated with front line rituximab-based regimens. Impact of recurrent mutations on progression-free survival in CLL patients treated with front line rituximab-based regimens.

Related projects

• Predictive stratification of CLL patients for therapy involving monoclonal antibodies targeting CD20
• Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit IV